Chapter 97 Shuguang goes public

At the headquarters of Nova Corporation, the lively atmosphere of the Chinese New Year has not affected this place.

Three brand new black business cars were parked under the administrative building of the headquarters. The three cars opened one after another, and a group of professional lawyers in suits and ties walked out of them.

A blond middle-aged man with an anxious look took the lead and strode towards the building, followed by a series of people, each holding a briefcase. Everyone looked serious and said nothing.

Nova Group was established in 1996 after the merger of two companies. Its development speed can be said to be unimaginable. In just a few years, it has become one of the top ten pharmaceutical groups in the world.

Create huge profits!

Twenty years later, Nova Group is one of the top three pharmaceutical groups in the world, with annual revenue of tens of billions of dollars, and is one of the top 500 global companies!

The group also has its own law firm, and today, all their elite lawyers came to the Nova headquarters to discuss important arrangements!

This arrangement is still related to Huaxia Future Pharmaceutical Company.

If the "Shuguang" launched by Chen Can is the most nervous and sensitive company, it must be Novavax!

As the owner of Glenin's patent, Nova is like owning a gold mine, and it also has the exclusive mining rights of this gold mine for twenty years.

If nothing unexpected happens, Novavax will gain tens of billions of dollars in revenue from the drug Glenin in the next two decades.

This is also the reason why Glenin attaches so much importance to the underground generic drug factory in Shanghai. If he wants to defend this gold mine, he must use thunderous means to deter those generic drug thieves.

And less than two months after 2003, a Chinese pharmaceutical company actually developed a new drug that could subvert glenin!

At present, Sugon's global patent has just been prepared for application, but Novavax has already sensed the danger.

No matter what, Novavax will not believe that a Chinese pharmaceutical company can develop an anti-cancer drug that is more perfect than their glenin!

If the other party's data is true, it can be said that Greining will be completely abandoned by the market in the future.

In other words, Nova Group is about to lose tens of billions of dollars!

Nova Corporation will not allow such a heavy loss under any circumstances!

Although it is still uncertain whether that dawn is really that magical, Nova will never let its opponents grow up before making a decision.

So today, all the elite lawyers of their group of lawyers are dispatched to study how to resist the "dawn" from China!

The board of directors of Nova Group also held meetings one after another to discuss this matter!

After several days of discussion, they finally decided to take a two-pronged approach!

The first way is to dispatch all the lawyers to formally sue Huaxia Future Pharmaceuticals for several crimes including patent infringement.

Although Chen Can's Shuguang is 100% self-owned patent, in this world, capitalists will never talk about right and wrong with you, they only talk about interests!

If we say that suing Huaxia Future Light will definitely lead to defeat, why does Novavax still do this?

The reason is very simple, dragging the word!

As long as prosecutions are initiated in various countries around the world, Sugon's patents will not be approved during this period.

Litigation costs money, a lot of money, even hundreds of millions of dollars!

And this time may be one or two years, or even several years!

Novavax is going to use these few years to drag down Sugon, a global patent company, and use money to drag down China Future Pharmaceuticals to death!

In fact, not only pharmaceutical groups, but every giant in the world today adopts this approach.

If a small and weak company invents a world-leading technology, its competitors will basically adopt this method.

As for the next step, it’s acquisition!

Yes, Novavax's second step is to send people to China to negotiate with Future Medicine!

You are a small Chinese company with a market value of less than 100 million U.S. dollars. How can you bring a lawsuit against us?

For the company's future revenue of tens of billions, Novavax can use hundreds of millions, or even hundreds of millions, of funds to drag out this lawsuit!

So, you better stop fighting with us. We are willing to pay 100 million US dollars to acquire the "Shuguang" formula in your hands. The next step of applying for a patent can be left to us, Novavax.

What a wonderful thing it would be for you to have 100 million US dollars, eat, drink and have fun!

Almost the same routines are common in any industry. The giants in all walks of life almost all use the same method to complete the harvest through suppression and acquisition, and finally form a monopoly group step by step.

This is capital!

But apparently, Novavax still underestimated Future Medicine, and it was not until early April that it sent a vice president of Novavax's Chinese branch to negotiate!

This is normal. It has only been a month since Chen Can applied for a global patent, and the domestic clinical application has not yet been approved. Novavax has also launched a comprehensive investigation into this "light of the future" within this month.

!

The results of the investigation let Nova breathe a sigh of relief.

Because there is no clinical data, the current global patent application is naturally nonsense.

Although the data on Sugon's drug looks very scary, Novavax has never believed that Shuguang's efficacy is better than that of Glenin.

Without the support of experimental data, everything is empty talk. Countless pharmaceutical companies around the world have spent years and hundreds of millions of dollars developing new drugs, only to end up in clinical trials.

As for Novavax, an investigation into Mirae Pharmaceuticals found that it took less than three months from acquisition to application for clinical application. Isn’t this nonsense?

A pharmaceutical company with no technical background actually claims to have developed a new drug that is several times more powerful than melinin. Novavax will not believe it no matter what!

Although Future Medicine claimed to have conducted animal experiments to prove the safety of Sugon, Novavax never believed it.

They know all about China's pharmaceutical companies better than anyone else!

At the beginning, the reason why Novavax was nervous was because Future Medicines had assigned a top global lawyer to be solely responsible for patent agency applications. This news really frightened Novavax.

After all, asking a top lawyer to apply for a global patent on your behalf would cost tens of millions, or even hundreds of millions, of dollars!

After all, applying for such a patent requires preparation for a lawsuit, so all the elite lawyers of Nova Group were mobilized at that time!

Although it has just begun, at least millions of dollars, or even tens of millions of dollars, have already been spent on future medicine!

That's why Novavax takes it extremely seriously, but after investigating the company "Future Medicine", Novavax is a little confused.

This company is a very small pharmaceutical company, not to mention in the world, even in China, it is not ranked high.

But such a company wants to apply for a global patent for "Shuguang"?

This is real gold and silver!

Finally, the elites of Nova Corporation gave an answer!

That is the real purpose of "future medicine", and perhaps it is not to apply for a patent for "Shuguang" and prepare for its launch.

The real purpose of this company is to blackmail Nova Corporation. All the company's current actions are to prepare to sell Dawn at a good price!

It is not surprising that Novavax came up with such an answer.

There are countless pharmaceutical-related industries around the world, including some small pharmaceutical companies and some independent laboratories.

In such small laboratories, through the establishment of innovative drug projects, some surprising chemical molecules are often developed. Usually, after these companies and laboratories have achieved certain results, they will contact the pharmaceutical giants as soon as possible to submit their own

The results are sold.

Often as long as a product has potential, it can be sold for hundreds of millions of dollars, or even hundreds of millions of dollars, making you rich overnight!

Don’t think that this is a rare event. In fact, in the pharmaceutical industry, most small companies and laboratories will choose to sell their research and development results during the first clinical phase, or even earlier.

The reason is very simple. Even if you really develop a world-changing result, with the power of your small company, you will not be able to bring this result to the market!

The reason for this is very simple, you can’t afford to waste time or money.

If you meet a pharmaceutical giant like Novavax, the two sides are still in a competitive relationship, and the other side will spend more money and time than you paid, and slowly kill you!

First block your way to apply for a patent, and then kill your company. If you are sensible, sell it at a low price and leave as soon as possible.

If you don’t know the signs, sorry, you will lose both life and money!

As for this new drug "Shuguang", which is said to have an efficacy that beats that of glenin, in Novavax's view, the real purpose of the drug is to sell it at a good price.

This "future medicine" company just wants to blackmail Novavax!

As for whether it was extortion, Novavax didn't care. In short, in more than a month, Novavax not only conducted a comprehensive investigation of Future Medicine, but also conducted experimental analysis on the new drug data of Sugon!

The results obtained surprised Nova Corporation!

Because of this dawn, some of its data do seem to be more powerful than melinin. This new drug has huge potential, and it is very likely that it can really subvert melinin.

Therefore, this has to attract Nova's attention once again.

But in negotiations, you can’t just reveal your trump card at once!

No, a vice president of Nova China Branch led a negotiation team to Future Medicine!

Liu Sihui took her team to receive Novavax, and the two parties immediately launched a series of business discussions.

The negotiations between the two parties were naturally not smooth. During the three days of negotiations, the demands of both parties were almost completely inconsistent.

Facing the strength of Novavax, Future Medicine is calm and calm, without any sense of urgency!

This gave Novavax a bit of a headache. In the end, the vice president offered a price of US$100 million, indicating that Novavax was willing to acquire all of Sugon's experimental data, including ownership.

In the end, Liu Sihui and others sent everyone at Novavax away with gifts, and the first negotiation ended on bad terms!

Obviously, this is just the beginning!
To be continued...